{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:31:51Z","timestamp":1784914311864,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005946","name":"Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16lm0103004"],"award-info":[{"award-number":["JP16lm0103004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.radonc.2025.110868","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:03:35Z","timestamp":1742681015000},"page":"110868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry study"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-8892","authenticated-orcid":false,"given":"Masaki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-9800","authenticated-orcid":false,"given":"Hiromitsu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3329-5999","authenticated-orcid":false,"given":"Masatoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tatebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-1688","authenticated-orcid":false,"given":"Takahiro","family":"Waki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-7665","authenticated-orcid":false,"given":"Sunao","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Satouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-3665","authenticated-orcid":false,"given":"Takayuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-7491","authenticated-orcid":false,"given":"Hidefumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110868_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.radonc.2025.110868_b0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jtho.2021.11.020","article-title":"Lung cancer in Japan","volume":"17","author":"Horinouchi","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2017.05.007","article-title":"Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review and hypothesis-generating meta-analysis","volume":"123","author":"Chi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijrobp.2018.02.022","article-title":"Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung cancer","volume":"101","author":"Nantavithya","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110868_b0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijrobp.2019.09.013","article-title":"Proton beam therapy for histologically or clinically diagnosed stage I non-small cell lung cancer (NSCLC): the first nationwide retrospective study in Japan","volume":"106","author":"Ohnishi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110868_b0035","unstructured":"Therneau T. A package for survival analysis in R. R package version 3.5-8, 2024."},{"key":"10.1016\/j.radonc.2025.110868_b0040","article-title":"\u2018Prodlim\u2019: product-limit estimation for censored event history analysis","author":"Gerds","year":"2023","journal-title":"R Package Version"},{"key":"10.1016\/j.radonc.2025.110868_b0045","first-page":"1","article-title":"MICE: multivariate imputation by chained equations in R","volume":"45","author":"Van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.radonc.2025.110868_b0050","unstructured":"Gray B. cmprsk: Subdistribution analysis of competing risks. R package version 2.2-12, 2024."},{"key":"10.1016\/j.radonc.2025.110868_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.110868_b0060","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110868_b0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2016.10.022","article-title":"Long-term outcome of phase I\/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer","volume":"122","author":"Chang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0070","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"3","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0075","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.3390\/cancers14174152","article-title":"Clinical outcomes following proton and photon stereotactic body radiation therapy for early-stage lung cancer","volume":"14","author":"Bae","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.110868_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results","author":"Levy","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0085","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ijrobp.2009.12.022","article-title":"Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer","volume":"79","author":"Matsuo","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110868_b0090","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1080\/0284186X.2019.1631476","article-title":"Survival after stereotactic radiotherapy in patients with early-stage non-small cell lung cancer","volume":"58","author":"Hansen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2017.08.026","article-title":"Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias","volume":"125","author":"Tsurugai","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2014.02.015","article-title":"Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study","volume":"84","author":"Ricardi","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.110868_b0105","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110868_b0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.21037\/tlcr.2018.04.01","article-title":"Considerations when treating lung cancer with passive scatter or active scanning proton therapy","volume":"7","author":"St James","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.radonc.2025.110868_b0115","first-page":"3","article-title":"Proton SBRT is ready to move past uncertainties and towards improved clinical outcomes","volume":"9","author":"Simone","year":"2023","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.radonc.2025.110868_b0120","first-page":"e493","article-title":"Is thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease?","volume":"34","author":"Saha","year":"2022","journal-title":"A Systematic Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109640","article-title":"Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: a Japanese national registry study (J-CROS-LUNG)","volume":"183","author":"Kubo","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110868_b0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J Thorac ardiovasc Surg"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402500163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402500163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:18:47Z","timestamp":1748017127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402500163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S016781402500163X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110868","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110868"}}